Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial
Publication date: Available online 12 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Aaron Baum, Joseph Scarpa, Emilie Bruzelius, Ronald Tamler, Sanjay Basu, James Faghmous Background The Action for Health in Diabetes (Look AHEAD) trial investigated whether long-term cardiovascular disease morbidity and mortality could be reduced through a weight loss intervention among people with type 2 diabetes. Despite finding no significant reduction in cardiovascular events on average, it is possible that some subpopulations might have derived benefit. In this post-hoc analysis, we test the hypothesis that t...
Source: The Lancet Diabetes and Endocrinology - July 13, 2017 Category: Endocrinology Source Type: research

Osteoporosis treatment: recent developments and ongoing challenges
Publication date: Available online 7 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Sundeep Khosla, Lorenz C Hofbauer Osteoporosis is an enormous and growing public health problem. Once considered an inevitable consequence of ageing, it is now eminently preventable and treatable. Ironically, despite tremendous therapeutic advances, there is an increasing treatment gap for patients at high fracture risk. In this Series paper, we trace the evolution of drug therapy for osteoporosis, which began in the 1940s with the demonstration by Fuller Albright that treatment with oestrogen could reverse the neg...
Source: The Lancet Diabetes and Endocrinology - July 8, 2017 Category: Endocrinology Source Type: research

Use of bone turnover markers in postmenopausal osteoporosis
Publication date: Available online 7 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Richard Eastell, Pawel Szulc Bone turnover comprises two processes: the removal of old bone (resorption) and the laying down of new bone (formation). N-terminal propeptide of type I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of bone formation and resorption, respectively, that are recommended for clinical use. Bone turnover markers can be measured on several occasions in one individual with good precision. However, these markers are subject to several sources of variability, includi...
Source: The Lancet Diabetes and Endocrinology - July 8, 2017 Category: Endocrinology Source Type: research

Diabetes in sub-Saharan Africa: let us not forget type 1
Publication date: Available online 5 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Silver K Bahendeka (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 6, 2017 Category: Endocrinology Source Type: research

Diabetes in sub-Saharan Africa: from clinical care to health policy
Publication date: Available online 5 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Rifat Atun, Justine I Davies, Edwin A M Gale, Till Bärnighausen, David Beran, Andre Pascal Kengne, Naomi S Levitt, Florence W Mangugu, Moffat J Nyirenda, Graham D Ogle, Kaushik Ramaiya, Nelson K Sew.ambo, Eugene Sobngwi, Solomon Tesfaye, John S Yudkin, Sanjay Basu, Christian Bommer, Esther Heesemann, Jennifer Manne-Goehler, Iryna Postolovska, Vera Sagalova, Sebastian Vollmer, Zulfiqarali G Abbas, Benjamin Ammon, Mulugeta Terekegn Angamo, Akhila Annamreddi, Ananya Awasthi, Stéphane Besançon, Sudha...
Source: The Lancet Diabetes and Endocrinology - July 6, 2017 Category: Endocrinology Source Type: research

The crisis of diabetes in sub-Saharan Africa
Publication date: Available online 5 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Shabbar Jaffar, Geoffrey Gill (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 6, 2017 Category: Endocrinology Source Type: research

SGLT2 inhibition: a new era in renoprotective medicine?
Publication date: Available online 27 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Marcel H A Muskiet, Hiddo J L Heerspink, Daniël H van Raalte (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 28, 2017 Category: Endocrinology Source Type: research

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
This study is completed and registered with ClinicalTrials.gov, number NCT01131676. Findings Between Sept 1, 2010, and April 22, 2013, we randomly assigned 7028 patients to treatment groups and 7020 patients received treatment. At baseline, we had UACR data for 6953 patients: 4171 (59% of treated patients; 1382 assigned to placebo and 2789 assigned to empagliflozin) had normoalbuminuria, 2013 (29%; 675 assigned to placebo and 1338 assigned to empagliflozin) had microalbuminuria, and 769 (11%; 260 assigned to placebo and 509 assigned to empagliflozin) had macroalbuminuria. Median treatment duration was 2·6 years (IQR...
Source: The Lancet Diabetes and Endocrinology - June 28, 2017 Category: Endocrinology Source Type: research

Sacubitril/valsartan in PARADIGM-HF – Authors' reply
Publication date: July 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 7 Author(s): Jelena P Seferovic, Brian Claggett, Scott D Solomon (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 21, 2017 Category: Endocrinology Source Type: research

Sacubitril/valsartan in PARADIGM-HF
Publication date: July 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 7 Author(s): Maya Guglin (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 21, 2017 Category: Endocrinology Source Type: research

The role of biosimilar manufacturers in improving access to insulin globally
Publication date: Available online 16 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Christophe Perrin, Margaret Ewen, David Beran (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 17, 2017 Category: Endocrinology Source Type: research

Metformin in type 1 diabetes
Publication date: Available online 11 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Eberhard Standl (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 13, 2017 Category: Endocrinology Source Type: research

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
Publication date: Available online 11 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein, Ronald Klein, Teik C Ooi, Peter Rossing, Coen D A Stehouwer, Naveed Sattar, Helen M Colhoun Background Metformin might reduce insulin requirement and improve glycaemia in patients with type 1 diabetes, but whether it has cardiovascular benefits is unknown. We aimed to investigate whether metformin treatment (added to titrated insulin therapy) reduced...
Source: The Lancet Diabetes and Endocrinology - June 13, 2017 Category: Endocrinology Source Type: research

Person-centred type 2 diabetes care: time for a paradigm shift
Publication date: Available online 9 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Guy E H M Rutten, Aus Alzaid (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 10, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017; published online June 7. http://dx.doi.org/10.1016/S2213-8587(17)30174-2
Publication date: Available online 8 June 2017 Source:The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 9, 2017 Category: Endocrinology Source Type: research

Should we officially recognise obesity as a disease?
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

Research digest: topical trials in thyroid disease
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): David Preiss, Steve Cleland, Naveed Sattar (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR –INDIAB population-based cross-sectional study
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Ranjit Mohan Anjana, Mohan Deepa, Rajendra Pradeepa, Jagadish Mahanta, Kanwar Narain, Hiranya Kumar Das, Prabha Adhikari, Paturi Vishnupriya Rao, Banshi Saboo, Ajay Kumar, Anil Bhansali, Mary John, Rosang Luaia, Taranga Reang, Somorjit Ningombam, Lobsang Jampa, Richard O Budnah, Nirmal Elangovan, Radhakrishnan Subashini, Ulagamathesan Venkatesan, Ranjit Unnikrishnan, Ashok Kumar Das, Sri Venkata Madhu, Mohammed K Ali, Arvind Pandey, Rupinder Singh Dhaliwal, Tanvir Kaur, Soumya Swaminathan, Viswanathan Mohan Backgro...
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

The need for improved diabetes care in India
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Vijay Viswanathan (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Publication date: Available online 30 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Tracy A Williams, Jacques W M Lenders, Paolo Mulatero, Jacopo Burrello, Marietta Rottenkolber, Christian Adolf, Fumitoshi Satoh, Laurence Amar, Marcus Quinkler, Jaap Deinum, Felix Beuschlein, Kanako K Kitamoto, Uyen Pham, Ryo Morimoto, Hironobu Umakoshi, Aleksander Prejbisz, Tomaz Kocjan, Mitsuhide Naruse, Michael Stowasser, Tetsuo Nishikawa, William F Young, Celso E Gomez-Sanchez, John W Funder, Martin Reincke Background Although unilateral primary aldosteronism is the most common surgically correctable cause of h...
Source: The Lancet Diabetes and Endocrinology - May 31, 2017 Category: Endocrinology Source Type: research

Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism
Publication date: Available online 30 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Olivier Steichen (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 31, 2017 Category: Endocrinology Source Type: research

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
Publication date: Available online 26 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Stephen Zewinger, Marcus E Kleber, Vinicius Tragante, Raymond O McCubrey, Amand F Schmidt, Kenan Direk, Ulrich Laufs, Christian Werner, Wolfgang Koenig, Dietrich Rothenbacher, Ute Mons, Lutz P Breitling, Herrmann Brenner, Richard T Jennings, Ioannis Petrakis, Sarah Triem, Mira Klug, Alexandra Filips, Stefan Blankenberg, Christoph Waldeyer, Christoph Sinning, Renate B Schnabel, Karl J Lackner, Efthymia Vlachopoulou, Ottar Nygård, Gard Frodahl Tveitevåg Svingen, Eva Ringdal Pedersen, Grethe S Tell, Juha S...
Source: The Lancet Diabetes and Endocrinology - May 27, 2017 Category: Endocrinology Source Type: research

Lipoprotein(a) and cardiovascular mortality: mystery still unsolved
Publication date: Available online 26 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Raul D Santos (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 27, 2017 Category: Endocrinology Source Type: research

Access to insulin: patients will pave the way
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Elizabeth R Rowley, James A Elliott, Fiona Conner, Philip Reed, John A Rowley (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Gestational vitamin D and childhood bone health – Authors' reply
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Audry H García, Oscar H Franco, Trudy Voortman (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Gestational vitamin D and childhood bone health
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Nicholas C Harvey, Rebecca Moon, Hazel M Inskip, Keith M Godfrey, Cyrus Cooper (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Bariatric surgery, glycaemic status, and microvascular complications – Authors' reply
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Lena M S Carlsson, Kajsa Sjöholm, Björn Carlsson, Markku Peltonen (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Bariatric surgery, glycaemic status, and microvascular complications
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Michael Bergman, Ram Jagannathan (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Diabetes care: putting patients front and centre
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Bone disease in diabetes: another manifestation of microvascular disease?
Publication date: Available online 22 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Vikram V Shanbhogue, Stinus Hansen, Morten Frost, Kim Brixen, Anne P Hermann Type 1 and type 2 diabetes are generally accepted to be associated with increased bone fracture risk. However, the pathophysiological mechanisms of diabetic bone disease are poorly understood, and whether the associated increased skeletal fragility is a comorbidity or a complication of diabetes remains under debate. Although there is some indication of a direct deleterious effect of microangiopathy on bone, the evidence is open to question...
Source: The Lancet Diabetes and Endocrinology - May 23, 2017 Category: Endocrinology Source Type: research

Safety of long-term denosumab therapy for osteoporosis
Publication date: Available online 22 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Juliet Compston (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 23, 2017 Category: Endocrinology Source Type: research

Puberty suppression in transgender children and adolescents
Publication date: Available online 22 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Simone Mahfouda, Julia K Moore, Aris Siafarikas, Florian D Zepf, Ashleigh Lin The World Professional Association for Transgender Health's standards of care recommend suspending puberty, preferably with the use of gonadotropin-releasing hormone agonists, in certain gender non-conforming minors (aged under 18 years) who have undergone a psychiatric assessment and have reached at least Tanner stage II of puberty. This approach seeks to lessen the discordance between assigned natal sex and gender identity by temporaril...
Source: The Lancet Diabetes and Endocrinology - May 23, 2017 Category: Endocrinology Source Type: research

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Publication date: Available online 22 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Henry G Bone, Rachel B Wagman, Maria L Brandi, Jacques P Brown, Roland Chapurlat, Steven R Cummings, Edward Czerwiński, Astrid Fahrleitner-Pammer, David L Kendler, Kurt Lippuner, Jean-Yves Reginster, Christian Roux, Jorge Malouf, Michelle N Bradley, Nadia S Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W Dempster, Socrates Papapoulos Background Long-term safety and efficacy of osteoporosis treatment are important because of the chronic nature of the disease. We aimed to assess the long-term safety...
Source: The Lancet Diabetes and Endocrinology - May 23, 2017 Category: Endocrinology Source Type: research

Artificial pancreas research: you can observe a lot by watching
Publication date: Available online 19 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Steven J Russell (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 20, 2017 Category: Endocrinology Source Type: research

Exercise and physical activity in patients with type 1 diabetes – Authors' reply
Publication date: Available online 19 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Michael C Riddell, Ian W Gallen, Remi Rabasa-Lhoret (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 20, 2017 Category: Endocrinology Source Type: research

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
This study is registered with PROSPERO, number 2015:CRD42015026854. Findings We identified 984 reports; after exclusions, 27 comparisons from 24 studies (23 crossover and one parallel design) including a total of 585 participants (219 in adult studies, 265 in paediatric studies, and 101 in combined studies) were eligible for analysis. Five comparisons assessed dual-hormone (insulin and glucagon), two comparisons assessed both dual-hormone and single-hormone (insulin only), and 20 comparisons assessed single-hormone artificial pancreas systems. Time in target was 12·59% higher with artificial pancreas systems (95% CI...
Source: The Lancet Diabetes and Endocrinology - May 20, 2017 Category: Endocrinology Source Type: research

Exercise and physical activity in patients with type 1 diabetes
Publication date: Available online 19 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Matthew D Campbell, Nicola Kime, James McKenna (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 20, 2017 Category: Endocrinology Source Type: research

PCSK9 inhibitors: smooth sailing or a little turbulence ahead?
Publication date: Available online 5 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Robert A Hegele (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 6, 2017 Category: Endocrinology Source Type: research

Can vitamin D prevent falls and fractures?
Publication date: Available online 28 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Roger Bouillon (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 29, 2017 Category: Endocrinology Source Type: research

Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial
Publication date: Available online 28 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Kay-Tee Khaw, Alistair W Stewart, Debbie Waayer, Carlene M M Lawes, Les Toop, Carlos A Camargo, Robert Scragg Background Adults with low concentrations of 25-hydroxyvitamin D (25[OH]D) in blood have an increased risk of falls and fractures, but randomised trials of vitamin D supplementation have had inconsistent results. We aimed to assess the effect of high-dose vitamin D supplementation on fractures and falls. Methods The Vitamin D Assessment (ViDA) Study was a randomised, double-blind, placebo-controlled trial...
Source: The Lancet Diabetes and Endocrinology - April 29, 2017 Category: Endocrinology Source Type: research

The global economic burden of diabetes in adults aged 20 –79 years: a cost-of-illness study
Publication date: Available online 26 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Christian Bommer, Esther Heesemann, Vera Sagalova, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Sebastian Vollmer Background Differences in methods and data used in past studies have limited comparisons of the cost of illness of diabetes across countries. We estimate the full global economic burden of diabetes in adults aged 20–79 years in 2015, using a unified framework across all countries. Our objective was to highlight patterns of diabetes-associated costs as well as to identify the need ...
Source: The Lancet Diabetes and Endocrinology - April 27, 2017 Category: Endocrinology Source Type: research

Global economic burden of diabetes and its implications
Publication date: Available online 26 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Ping Zhang, Edward Gregg (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 27, 2017 Category: Endocrinology Source Type: research

Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial
Publication date: Available online 24 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Juliane Menting, Cees J Tack, Arianne C van Bon, Henry J Jansen, Joop P van den Bergh, Marc J T M Mol, Martine M Goedendorp, Rogier Donders, Hans Knoop Background Fatigue in type 1 diabetes is prevalent and persistent, but so far, no evidence-based treatments are available. We aimed to investigate the efficacy of cognitive behavioural therapy (CBT) in reducing fatigue severity in patients with type 1 diabetes. Methods We did a multicentre randomised controlled trial at one university medical centre and four large...
Source: The Lancet Diabetes and Endocrinology - April 25, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017; 5: 325 –26
Publication date: Available online 24 April 2017 Source:The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 25, 2017 Category: Endocrinology Source Type: research

Has the UK really become iodine sufficient?
Publication date: Available online 24 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Sarah C Bath, Margaret P Rayman (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 25, 2017 Category: Endocrinology Source Type: research

Fatigue in type 1 diabetes: an understudied problem
Publication date: Available online 24 April 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Frans Pouwer (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 25, 2017 Category: Endocrinology Source Type: research

Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure
Publication date: May 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 5 Author(s): Lars Rydén, Frans Van de Werf, Paul W Armstrong, Darren K McGuire, Eberhard Standl, Eric D Peterson, Rury R Holman (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 25, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017; 5: 240 –41
Publication date: May 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 5 (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 22, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017: 5: 174 –83
Publication date: May 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 5 (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 22, 2017 Category: Endocrinology Source Type: research

Semaglutide, lipid-lowering drugs, and NAFLD – Author's reply
Publication date: May 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 5 Author(s): Christopher Sorli (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 22, 2017 Category: Endocrinology Source Type: research